NDC 0002-3251

Strattera

Atomoxetine Hydrochloride

Strattera is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Atomoxetine Hydrochloride.

Product ID0002-3251_67a53369-eead-4f2c-afe9-f3274899c47e
NDC0002-3251
Product TypeHuman Prescription Drug
Proprietary NameStrattera
Generic NameAtomoxetine Hydrochloride
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2005-02-14
Marketing CategoryNDA / NDA
Application NumberNDA021411
Labeler NameEli Lilly and Company
Substance NameATOMOXETINE HYDROCHLORIDE
Active Ingredient Strength100 mg/1
Pharm ClassesNorepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0002-3251-30

30 CAPSULE in 1 BOTTLE (0002-3251-30)
Marketing Start Date2005-08-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0002-3251-30 [00002325130]

Strattera CAPSULE
Marketing CategoryNDA
Application NumberNDA021411
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-08-24

Drug Details

Active Ingredients

IngredientStrength
ATOMOXETINE HYDROCHLORIDE100 mg/1

OpenFDA Data

SPL SET ID:309de576-c318-404a-bc15-660c2b1876fb
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 617945
  • 608139
  • 349592
  • 349593
  • 349591
  • 349594
  • 349595
  • 352321
  • 352320
  • 617947
  • 352317
  • 352318
  • 352319
  • 608143
    • UPC Code
  • 0300023229304
  • 0300023228307
  • 0300023238306
  • 0300023239303
  • 0300023251305
  • 0300023250308
  • 0300023227300

    • Pharmacological Class

    • Norepinephrine Reuptake Inhibitor [EPC]
    • Norepinephrine Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "Strattera" or generic name "Atomoxetine Hydrochloride"

    NDCBrand NameGeneric Name
    0002-3227StratteraAtomoxetine hydrochloride
    0002-3228StratteraAtomoxetine hydrochloride
    0002-3229StratteraAtomoxetine hydrochloride
    0002-3238StratteraAtomoxetine hydrochloride
    0002-3239StratteraAtomoxetine hydrochloride
    0002-3250StratteraAtomoxetine hydrochloride
    0002-3251StratteraAtomoxetine hydrochloride
    49999-636StratteraAtomoxetine
    68151-4486StratteraStrattera
    68151-4487StratteraStrattera
    68151-4484StratteraStrattera
    68151-4485StratteraStrattera
    68151-4488StratteraStrattera
    64725-3228StratteraStrattera
    0781-2260Atomoxetine hydrochlorideAtomoxetine hydrochloride
    0781-2261Atomoxetine hydrochlorideAtomoxetine hydrochloride
    0781-2262Atomoxetine hydrochlorideAtomoxetine hydrochloride
    0781-2263Atomoxetine hydrochlorideAtomoxetine hydrochloride
    0781-2264Atomoxetine hydrochlorideAtomoxetine hydrochloride
    0781-2265Atomoxetine hydrochlorideAtomoxetine hydrochloride
    0781-2266Atomoxetine hydrochlorideAtomoxetine hydrochloride
    50090-4235Atomoxetine Hydrochlorideatomoxetine hydrochloride
    50090-4236Atomoxetine Hydrochlorideatomoxetine hydrochloride
    50090-4237Atomoxetine Hydrochlorideatomoxetine hydrochloride
    50090-4243Atomoxetine Hydrochlorideatomoxetine hydrochloride

    Trademark Results [Strattera]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    STRATTERA
    STRATTERA
    76306506 2727937 Live/Registered
    Eli Lilly and Company
    2001-08-29
    STRATTERA
    STRATTERA
    75577404 not registered Dead/Abandoned
    Eli Lilly and Company
    1998-10-26
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.